Cfo Thought Leader

Within 4 months of her 2019 arrival inside BDSI’s CFO office, Terry Coelho had spearheaded a product acquisition and managed a successful equity raise—two finance milestones that would produce generous sales tailwinds for the specialty pharmaceutical firm.   BDSI would experience 100% net sales growth in 2019, followed by 40% net sales growth in 2020.  Such sales momentum recently led BDSI to issue a press release praising its “new commercial team” and at the same time announcing that Coelho’s CFO title would now include the designation “executive vice president.” For Coelho, a seasoned finance executive who spent more than a decade serving in a variety of senior positions inside Novartis and Sealed Air Corp., the call to leadership at BDSI afforded her a wide berth from which deliver results that are now arguably visible to all. Still, even this success chapter must compete for our attention when we hear about a promotion that she received from candy and pet food giant Mars Incorporated early in her career.